651 related articles for article (PubMed ID: 1377411)
1. Valproic acid-induced spina bifida: a mouse model.
Ehlers K; Stürje H; Merker HJ; Nau H
Teratology; 1992 Feb; 45(2):145-54. PubMed ID: 1377411
[TBL] [Abstract][Full Text] [Related]
2. Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity.
Ehlers K; Stürje H; Merker HJ; Nau H
Teratology; 1992 Aug; 46(2):117-30. PubMed ID: 1440416
[TBL] [Abstract][Full Text] [Related]
3. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
Padmanabhan R; Hameed MS
J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
[TBL] [Abstract][Full Text] [Related]
4. The valproic acid metabolite E-2-n-propyl-2-pentenoic acid does not induce spina bifida in the mouse.
Ehlers K; Stürje H; Merker HJ; Nau H
Dev Pharmacol Ther; 1992; 19(4):196-204. PubMed ID: 1343622
[TBL] [Abstract][Full Text] [Related]
5. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid sodium-induced spina bifida occulta in the rat.
Ceylan S; Duru S; Ceylan S
Neurosurg Rev; 2001 Mar; 24(1):31-4. PubMed ID: 11339465
[TBL] [Abstract][Full Text] [Related]
7. New animal model for the study of neural tube defects.
Michejda M; McCollough D
Z Kinderchir; 1987 Dec; 42 Suppl 1():32-5. PubMed ID: 3124366
[TBL] [Abstract][Full Text] [Related]
8. Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics.
Ehlers K; Elmazar MM; Nau H
J Nutr; 1996 Jan; 126(1):67-75. PubMed ID: 8558327
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
Nau H; Hauck RS; Ehlers K
Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
[TBL] [Abstract][Full Text] [Related]
10. Development of the skeleton in normal rats and in rats with trypan blue induced spina bifida.
Peters PW; Verhoef A; De Liefde A; Berkvens JM
Acta Morphol Neerl Scand; 1981 Mar; 19(1):21-34. PubMed ID: 7020357
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effects of retinoic acid given during the critical period for inducing spina bifida in mice and hamsters.
Tibbles L; Wiley MJ
Teratology; 1988 Feb; 37(2):113-25. PubMed ID: 3281303
[TBL] [Abstract][Full Text] [Related]
12. Gene-teratogen interaction and its morphological basis in retinoic acid-induced mouse spina bifida.
Kapron-Brás CM; Trasler DG
Teratology; 1984 Aug; 30(1):143-50. PubMed ID: 6385329
[TBL] [Abstract][Full Text] [Related]
13. Discontinuity of primary and secondary neural tube in spina bifida induced by retinoic acid in mice.
Yasuda Y; Konishi H; Kihara T; Tanimura T
Teratology; 1990 Mar; 41(3):257-74. PubMed ID: 2183387
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of motor neurons of the levator ani muscle in fetal rats with spina bifida occulta.
Li Y; Hou XY; Yuan ZW; Wang WL
Surg Neurol; 2009 Dec; 72(6):652-6; discussion 656. PubMed ID: 19328533
[TBL] [Abstract][Full Text] [Related]
15. Amidic modification of valproic acid reduces skeletal teratogenicity in mice.
Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910
[TBL] [Abstract][Full Text] [Related]
16. A mouse model for neural tube defects: the curtailed (Tc) mutation produces spina bifida occulta in Tc/+ animals and spina bifida with meningomyelocele in Tc/t.
Park CH; Pruitt JH; Bennett D
Teratology; 1989 Mar; 39(3):303-12. PubMed ID: 2658196
[TBL] [Abstract][Full Text] [Related]
17. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
[TBL] [Abstract][Full Text] [Related]
18. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
20. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
Sato M; Shirota M; Nagao T
Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
